• レポートコード:PMR2201A059 • 出版社/出版日:Persistence Market Research / 2021年12月20日 • レポート形態:英文、PDF、245ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Site Licence | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Enterprisewide | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界の調剤薬局市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の影響分析、市場需要分析/予測、製品別(経口薬カプセル、局所薬、うがい薬、坐剤)分析、用途別(大人用、動物用、子供用、高齢者用)分析、治療別(疼痛管理、ホルモン補充治療)分析、地域別分析、主要国分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の影響分析 ・市場需要分析/予測 ・世界の調剤薬局市場規模:製品別(経口薬カプセル、局所薬、うがい薬、坐剤) ・世界の調剤薬局市場規模:用途別(大人用、動物用、子供用、高齢者用) ・世界の調剤薬局市場規模:治療別(疼痛管理、ホルモン補充治療) ・世界の調剤薬局市場規模:地域別 ・主要国分析 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Compounding Pharmacies Market – Scope of Report
The latest publication by Persistence Market Research on the compounding pharmacies market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for compounding pharmacies market and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the compounding pharmacies market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the compounding pharmacies market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the compounding pharmacies market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the compounding pharmacies market offers information divided into five important segments — product, application, therapeutic area, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Oral Medication Capsules
Tablets
Mixtures
Lollipops
Lozenges
Topical Medication
Gels
Ointments
Cream
Lotions
Mouthwashes
Suppositories
Application
Medication for Adults
Veterinary Medication
Medication for Children
Geriatric Medication
Therapeutic Area
Pain Management
Hormone Replacement Therapy
Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for compounding pharmacies over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the compounding pharmacies market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the compounding pharmacies market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the compounding pharmacies market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
1.3. Wheel of Fortune
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Trends in Diverse Applications
4. Key Success Factors
4.1. Product Type Adoption Rate/Usage Analysis- Key Statistics
4.2. Key Regulations, by Region
4.3. PEST Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Market Outlook
5.1.3. Income Per Capita Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Increasing Medicinal Droughts of Prescription Medicine
5.2.2. Growing demand for HRT drugs
5.2.3. Examples of Upcoming HRTs
5.2.4. Pain Management Therapies are Driving the Growth of the Market
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.4.1.1. Revenue By Product
6.4.1.2. Revenue By Application
6.4.1.3. Revenue By Therapeutic Area
6.4.1.4. Revenue By Country
6.5. 2020 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021-2031
8.3.1. Oral Medication Capsule
8.3.1.1.1. Tablets
8.3.1.1.2. Mixtures
8.3.1.1.3. Lollipops
8.3.1.1.4. Lozenges
8.3.2. Topical Medication
8.3.2.1.1. Gels
8.3.2.1.2. Ointments
8.3.2.1.3. Cream
8.3.2.1.4. Lotions
8.3.3. Mouthwashes
8.3.4. Suppositories
8.4. Market Attractiveness Analysis By Product
9. Global Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016 – 2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021 – 2031
9.3.1. Medication For Adults
9.3.2. Medication for Veterinary
9.3.3. Medication for Children
9.3.4. Medication for Geriatric
9.4. Market Attractiveness Analysis By Application
10. Global Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Therapeutic Area
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Area, 2016 – 2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Area, 2021 – 2031
10.3.1. Pain Management
10.3.2. Hormone Replacement Therapy
10.4. Market Attractiveness Analysis By Application
11. Global Compounding Pharmacies Market 2016-2020 and Forecast 2021-2031, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis By Region
12. North America Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
12.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1.1. U.S.
12.3.1.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By Therapeutic Area
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
13.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Application
13.3.4. By Therapeutic Area
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
14.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Application
14.3.4. By Therapeutic Area
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Application
15.3.4. By Therapeutic Area
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Application
16.3.4. By Therapeutic Area
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
17.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Application
17.3.4. By Therapeutic Area
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020
18.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Application
18.3.4. By Therapeutic Area
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Key and Emerging Countries Compounding Pharmacies Market Analysis 2021 & 2031
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.2.1. By Product
19.2.2. By Application
19.2.3. By Therapeutic Area
19.3. Canada Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.3.1. By Product
19.3.2. By Application
19.3.3. By Therapeutic Area
19.4. Mexico Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.4.1. By Product
19.4.2. By Application
19.4.3. By Therapeutic Area
19.5. Brazil Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.5.1. By Product
19.5.2. By Application
19.5.3. By Therapeutic Area
19.6. Argentina Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.6.1. By Product
19.6.2. By Application
19.6.3. By Therapeutic Area
19.7. U.K. Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.7.1. By Product
19.7.2. By Application
19.7.3. By Therapeutic Area
19.8. Germany Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.8.1. By Product
19.8.2. By Application
19.8.3. By Therapeutic Area
19.9. France Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.9.1. By Product
19.9.2. By Application
19.9.3. By Therapeutic Area
19.10. Italy Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.10.1. By Product
19.10.2. By Application
19.10.3. By Therapeutic Area
19.11. Spain Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.11.1. By Product
19.11.2. By Application
19.11.3. By Therapeutic Area
19.12. BENELUX Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.12.1. By Product
19.12.2. By Application
19.12.3. By Therapeutic Area
19.13. Russia Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.13.1. By Product
19.13.2. By Application
19.13.3. By Therapeutic Area
19.14. China Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.14.1. By Product
19.14.2. By Application
19.14.3. By Therapeutic Area
19.15. Japan Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.15.1. By Product
19.15.2. By Application
19.15.3. By Therapeutic Area
19.16. South Korea Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.16.1. By Product
19.16.2. By Application
19.16.3. By Therapeutic Area
19.17. India Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.17.1. By Product
19.17.2. By Application
19.17.3. By Therapeutic Area
19.18. ASEAN Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.18.1. By Product
19.18.2. By Application
19.18.3. By Therapeutic Area
19.19. Australia Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.19.1. By Product
19.19.2. By Application
19.19.3. By Therapeutic Area
19.20. New Zealand Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.20.1. By Product
19.20.2. By Application
19.20.3. By Therapeutic Area
19.21. GCC Countries Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.21.1. By Product
19.21.2. By Application
19.21.3. By Therapeutic Area
19.22. Turkey Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.22.1. By Product
19.22.2. By Application
19.22.3. By Therapeutic Area
19.23. South Africa Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031
19.23.1. By Product
19.23.2. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Company Share Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive (Company List)
21.2.1. Fagron
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/ Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.1.5.1. Marketing Strategy
21.2.1.5.2. Product Strategy
21.2.2. Fresenius Kabi AG
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/ Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.2.5.1. Marketing Strategy
21.2.2.5.2. Product Strategy
21.2.3. PharMEDium Services, LLC,
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/ Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.3.5.1. Marketing Strategy
21.2.3.5.2. Product Strategy
21.2.4. Institutional Pharmacy Solutions
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/ Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.4.5.1. Marketing Strategy
21.2.4.5.2. Product Strategy
21.2.5. Cantrell Drug Company
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/ Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.5.5.1. Marketing Strategy
21.2.5.5.2. Product Strategy
21.2.6. Lorraine’s Pharmacy
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/ Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.6.5.1. Marketing Strategy
21.2.6.5.2. Product Strategy
21.2.7. B. Braun Melsungen AG Company.
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/ Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.7.5.1. Marketing Strategy
21.2.7.5.2. Product Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Table 01: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By RegionTable 02: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type
Table 03: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application
Table 04: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area
Table 05: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country
Table 06: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type
Table 07: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application
Table 08: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area
Table 09: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country
Table 10: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type
Table 11: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application
Table 12: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area
Table 13: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country
Table 14: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type
Table 15: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application
Table 16: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area
Table 17: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country
Table 18: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type
Table 19: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application
Table 20: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area
Table 21: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country
Table 22: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type
Table 23: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application
Table 24: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area